Akadēmiskais centrsStarptautiski citētās publikācijas
Pasaules mēroga citēšanas indeksu sarakstos (PubMed, Scopus, Web of Science, Google Scholar u. c.) ietvertie izdevumi
1. Leja M, Axon A, Brenner H. Epidemiology of Helicobacter pylori infection. Helicobacter. 2016
2. Mezinska S, Kakuk P, Mijaljica G, Waligóra M, O'Mathúna DP. Research in disaster settings: a systematic qualitative review of ethical guidelines. BMC Med Ethics. 2016
3. Shehada N, Cancilla JC, Torrecilla JS, Pariente ES, Brönstrup G, Christiansen S, Johnson DW, Leja M, Davies MP, Liran O, Peled N, Haick H. Silicon Nanowire Sensors Enable Diagnosis of Patients via Exhaled Breath. ACS Nano. 2016
4. Leja M, Amal H, Lasina I, Skapars R, Sivins A, Ancans G, Tolmanis I, Vanags A, Kupcinskas J, Ramonaite R, Khatib S, Bdarneh S, Natour R, Ashkar A, Haick H. Analysis of the effects of microbiome-related confounding factors on the reproducibility of the volatolomic test. J Breath Res. 2016
5. Amal H, Leja M, Funka K, Skapars R, Sivins A, Ancans G, Liepniece-Karele I, Kikuste I, Lasina I, Haick H. Detection of precancerous gastric lesions and gastric cancer through exhaled breath. Gut. 2016
6. Santare D, Kojalo I, Liepniece-Karele I, Kikuste I, Tolmanis I, Polaka I, Vikmanis U, Boka V, Leja M. Comparison of the yield from two faecal immunochemical tests at identical cutoff concentrations - a randomized trial in Latvia. Eur J Gastroenterol Hepatol. 2016
7. Daugule I, Karklina D, Rudzite D, Remberga S, Rumba-Rozenfelde I. Prevalence of Helicobacter pylori infection among preschool children in Latvia: no significant decrease in prevalence during a ten year period. Scand J Public Health. 2016
8. Kurilovich S, Belkovets A, Reshetnikov O, Openko T, Malyutina S, Ragino Y, Scherbakova L, Leja M, Paloheimo L, Syrjänen K, Voevoda M. Stomach-specific Biomarkers (GastroPanel) Can Predict the Development of Gastric Cancer in a Caucasian Population: A Longitudinal Nested Case-Control Study in Siberia. Anticancer Res. 2016
9. Amal H, Leja M, Funka K, Lasina I, Skapars R, Sivins A, Ancans G, Kikuste I, Vanags A, Tolmanis I, Kirsners A, Kupcinskas L, Haick H. Breath testing as potential colorectal cancer screening tool. Int J Cancer. 2016
10. Stagg, H.R., White, P.J., Riekstiņa, V., Cīrule, A., Šķenders, Ģ. et al; Decreased time to treatment initiation for multidrug-resistant tuberculosis patients after use of xpert MTB/RIF Test, Latvia; Emerging Infectious Diseases. 2016
11. Kurilovich, S., Belkovets, A., Reshetnikov, O., Openko, T., Malyutina, S., Ragino, Y., Scherbakova, L., Leja, M., Paloheimo, L., Syrjänen, K., Voevoda, M.; Stomach-specific biomarkers (GastroPanel) can predict the development of gastric cancer in a Caucasian population: A longitudinal nested case-control study in Siberia; Anticancer Research. 2016.
12. Young, G.P., Senore, C., Mandel, J.S., Allison, J.E., Atkin, W.S., ..., Leja, M., ...; Recommendations for a step-wise comparative approach to the evaluation of new screening tests for colorectal cancer; Cancer. 2016.
13. Ilze Apine, Juris Pokrotnieks, Mārcis Leja, Santa Atteka, Gaida Krūmiņa; MRI apparent diffusion coefficient values in collapsed and distended small bowel loops and their potential importance for excluding inflammatory bowel disease: a study in healthy subjects, Acta Chirurgica Latviensis, 2016. 1. Sēj.
Publikācijas Latvijas zinātniskos izdevumos
LZA Vēstis, u. c.
1. Apine I., Pokrotnieks J., Leja M., Atteka S., Krumina G. MRI Apparent Diffusion Coefficient Values in Collapsed and Distended Small Bowel Loops and their Potential Importance for excluding Inflammatory Bowel Disease: A Study in Health Subjects. Acta Chirurgica Latviensis, 2016: 1, 23-30.
Nozīmīgākās tēzes starptautiskās konferencēs
1. M. Leja, A. Rudule, J.Y. Park, R. Murillo, I. Liepniece-Karele, S. Isajevs, et al. The preliminary results of GISTAR pilot study in Latvia. XXIXth International Workshop on Helicobacter & Microbiota in Inflammation and Cancer. Magdeburg, Germany: European Helicobacter & Microbiota Study Group; 2016. pp. 72.
2. Sjomina O., Pavlova J., Janovic P., Kikuste I., Vanags A., Tolmanis I., et al. Is pepsinogen screening in general Caucasian population justified: results from a cross-sectional population study in Latvia. XXIXth International Workshop on Helicobacter and Microbiota in Inflammation and Cancer. Magdeburg, Germany: European Helicobacter & Microbiota Study Group; 2016.
3. J. Pavlova, O. Sjomina, P. Janovic, I. Kikuste, A. Vanags, I. Tolmanis, et al. Dynamics of pepsinogen values in an average and high-risk Caucasian population within a median 3.5 year follow-up period. XXIXth International Workshop on Helicobacter and Microbiota in Inflammation and Cancer. Magdeburg, Germany: European Helicobacter & Microbiota Study Group; 2016. pp. 123.
4. S. Isajevs, M.B. Piazuelo, A. Belkovets, O. Reshetnikov, P. Bessonov, S. Kurilovich, et al. The prevalence of gastric premalignant lesions in inuit population from Yakutia, Russia. XXIXth International Workshop on Helicobacter and Microbiota in Inflammation and Cancer. Magdeburg, Germany: European Helicobacter & Microbiota Study Group; 2016. pp. 126-127.
5. S. Skrebinska, D. Santare, S. Isajevs, I. Liepniece-Karele, D. Rudzite, I. Kikuste, et al. Comparative evaluation of two serological tests for detection of H.pylori infection in Latvian population. XXIXth International Workshop on Helicobacter and Microbiota in Inflammation and Cancer. Magdeburg, Germany: European Helicobacter & Microbiota Study Group; 2016. pp. 97.
6. S. Skrebinska, J. Zavoronkova, D. Santare, S. Isajevs, I. Liepniece-Karele, D. Rudzite, et al. The accuracy of EIA-based stool antigen test for detection of H.pylori infection in a high prevalence country. XXIXth International Workshop on Helicobacter and Microbiota in Inflammation and Cancer. Magdeburg, Germany: European Helicobacter & Microbiota Study Group; 2016.
7. A. Urke, P. Krike, Z. Shums, D. Rudzite, I. Polaka, A Sivins, et al. The prevalence of anti-parietal cell and intrinsic factor antibodies in patients with gastric adenocarcinoma. XXIXth International Workshop on Helicobacter and Microbiota in Inflammation and Cancer. Magdeburg, Germany: European Helicobacter & Microbiota Study Group; 2016. pp. 130-131.
8. P. Krike, Z. Shums, D. Rudzite, I. Polaka, S. Isajevs, G.L. Norman, et al. The prevalence of anti-parietal cell and anti-intrinsic factor antibodies, pepsinogens, gastrin-17 and H.pylori infection in corpus-restricted gastritis patients. XXIXth International Workshop on Helicobacter and Microbiota in Inflammation and Cancer. Magdeburg, Germany: European Helicobacter & Microbiota Study Group; 2016. pp. 161-162.
9. Sjomina O., Pavlova J., Janovic P., Kikuste I., Vanags A., Tolmanis I., et al. Yield of pepsinogen testing in a general population sample of caucasian origin. UEGW 2016, 24th Vienna, Austria; 2016. pp. 696.
10. Urke A., P.Krike, D.Shums, D.Rudzite, Polaka I., Sivins A., et al. The prevalence of autoimmune gastritis in Caucasians with gastric adenocarcinoma UEGW 2016, 24th Vienna, Austria; 2016. pp. 304.
11. Krike P., Shums Z., Rudzite D., Polaka I., Isajevs S., Norman G.L., et al. The prevalence of anti-parietal cell and anti-intrinsic factor antibodies, pepsinogen and gastrin-17 in corpus-restricted gastritis patient. UEGW 2016, 24th Vienna, Austria; 2016. pp. 303.
12. Sjomina O., Pavlova J., Janovic P., Kikuste I., Vanags A., Tolmanis I., et al. Yield of pepsinogen testing in a general population sample of caucasian origin. UEGW 2016, 24th Vienna, Austria; 2016. pp. 696.
13. Leja M., Rudule A., Park J.Y., Murillo R., Liepniece-Karele I., Isajevs S., et al. GISTAR pilot study: group description and preliminary results. UEGW 2016, 24th Vienna, Ausria; 2016. pp. 331.
14. Leja M., Gasenko E., Polaka I., Murillo R., Bordin D., Link A., et al. How do international gastric cancer prevention guidelines reflect to clinical practice globally? In: UEGW 2016, 24th Vienna, Austria; 2016. pp. 513.
15. Leja M. Breath volatile markers for gastrointestinal cancer detection. UEGW 2016, 24th Vienna, Austria 2016.
16. Kojalo Una, Šantare Daiga, Kojalo Ilona, Leja Mārcis. Characteristics of the non-responder groups of the colorectal cancer screening pilot study in Latvia. UEGW 2016, 24th Vienna, Austria; 2016. pp. 473.
17. Apine I., Pokrotnieks J., Leja M., Atteka S., Pukite I., Krumina G. Measuring apparent diffusion coefficient values in collapsed and distended small bowel loops has a potential in excluding inflammatory bowel disease in patients without bowel preparation: a study in healthy subjects. UEGW 2016, 24th Vienna, Austria; 2016. pp. 435.
18. Ābols A., Šantare D., Toleikiene R., Zandberga E., Kalniņa Z., Vangravs R., et al. Carbonic anhydrase IX as the marker of the hypoxia induced extracellular vesicle secretion. UEGW 2016, 24th Vienna, Austria: UEG journal; 2016. pp. 284.
19. Apine I., Pokrotnieks J., Leja M., Atteka S., Pukite I., Krumina G. Measuring apparent diffusion coefficient values in collapsed and distended small bowel loops has a potential in excluding inflammatory bowel disease in patients without bowel preparation: a study in healthy subjects. UEGW Abstracts. UEGJ, 2016, 3 (S5), A435 (P0825).
20. Anna Vyazovaya, Igor Mokrousov, Ilva Pole, Natalia Solovieva, Tatyana Umpeleva, Yuriy Skiba, Sahal Al-Hajoj Al-Nakhli, Bright Varghese, Ruslan Ludannyy, Maria Alvarez Figueroa, Ģirts Šķenders, Renate Ranka, Inta Jansone, Viatcheslav Zhuravlev, Olga Narvskaya. Multidrug-resistant clone Myсobacterium tuberculosis LAM SIT252 emerging in some regions of European Russia and Eastern Europe. Poster. Annual Congress of the European Society of Mycobacteriology. 03-06.07.2016. Catania, Sicily.
21. Ilva Pole, Iveta Ozere, Inta Jansone, Ģirts Šķenders, Anda Nodieva, Olga Bobrikova, Zita Lauska, Marcis Kristons, Liga Embrasa, Viktorija Igumnova, Inga Norvaisa, Renate Ranka. Analysis of M. tuberculosis genotypes in epidemiologically linked TB patients. Poster. Annual Congress of the European Society of Mycobacteriology. 03-06.07.2016. Catania, Sicily.
22. Ivars Silamikelis, Davids Fridmanis, Ilze Radovica-Spalvina, Ģirts Šķenders, Ilva Pole, Inta Jansone, Renate Ranka, Janis Klovins. Insight in diversity of Mycobacterium tuberculosis strains from Latvia based on whole genome sequencing. Poster. Annual Congress of the European Society of Mycobacteriology. 03-06.07.2016. Catania, Sicily.
23. Ilva Pole, Inta jansone, Iveta Ozere, Anda Nodieva, Ģirts Šķenders, Inga Norvaiša, Renāte Ranka. Molecular genotyping of mycobacterium tuberculosis for detection of local tb outbreaks in Latvia. 1st International Forum on Tuberculosis in Central and Eastern Europe. 04.11-06.11.16 Warsaw, Poland. Oral presentation.
Svarīgākās tēzes nacionālā līmeņa simpozijos, konferencēs, kongresos
1. E. Gašenko, I. Polaka, A. Hegmane, R. Škapars, D. Bordin, L. Garkalne, et al. Gastric cancer screening questionnaire, preliminary results. Latvijas Universitātes 74. konferences Medicīnas sekcija. Rīga, Latvia: Latvijas Universitāte; 2016.
2. I. Kikuste, S. Isajevs, I. Liepniece-Karele, D. Jančauskas, M. Leja. Helicobacter pylori infection and associations according to OLGA and OLGIM stages. Latvijas Universitātes 74. konferences Medicīnas sekcija. Rīga, Latvija: Latvijas Universitāte; 2016.
3. I. Lasina, I. Andina, S. Cui, L. Rozkalne, K. Veinberga, I. Kikuste, et al. H. Pylori eradication prescriptions and success in general practice. Latvijas Universitātes 74. konferences Medicīnas sekcija. Rīga, Latvia: Latvijas Universitāte; 2016.
4. I. Zandberga, I. Polaka, P. Krike, A. Rudule, S. Parsutins, R. Murillo, et al. Factors influencing participation in “search-and-treat” strategy for H.pylori to prevent gastric cancer and other infection-related diseases. Latvijas Universitātes 74. konferences Medicīnas sekcija. Riga, Latvia: Latvijas Universitāte; 2016.
5. J. Žavoronkova, A. Rūdule, D. Rudzīte, D. Santare, R. Murillo, J. Young-Park, et al. Helicobacter pylori infection among patients with allergy in Latvian population. Latvijas Universitātes 74. konferences Medicīnas sekcija. Rīga, Latvia: Latvijas Universitāte; 2016.
6. J. Žavoronkova, D. Šantare, H. Amal, S. Isajevs, I. Liepniece-Karele, D. Rudzīte, et al. Overview of preliminary results about the accuracy of serology and stool antigen test for detection of H. Pylori infection in relation to histology. Latvijas Universitātes 74 konferences Medicīnas sekcija. Rīga; 2016.
7. P. Krike, I. Polaka, A. Rudule, I. Park, R. Murillo, R. Herrero, et al. Participation rate in the GISTAR pilot study: the results from a single recruitment centre. Latvijas Universitātes 74 konferences Medicīnas sekcija. Rīga, Latvia: Latvijas Universitāte; 2016.
8. S. Isajevs, F. Lozupone, N. Zarovni, A. Chiesi, P. Guazzi, M. Leja. Tm9sf4, Cd9a and Tm9sf3 expression in premalignant lesions, gastric and colorectal carcinoma. Latvijas Universitātes 74. konferences Medicīnas sekcija. Rīga, Latvija: Latvijas Universitātes; 2016.
9. S. Krampāne, I. Lašina, I. Andiņa, S. Čui, L. Rožkalne, K. Veinberga, et al. H.pylori eradication therapy appropriation and success in Latvia: data from European registry study. Latvijas Universitātes 74. konferences Medicīnas sekcija. Rīga, Latvia: Latvijas Universitāte; 2016.
10. I. Grīnberga-Dērica, A. Bušmane, I. Daugule, A. Rūdule, D. Rudzīte, D. Šantare, et al. Association between Helicobacter Pylori infection and socioeconimic factors in Latvian population. Latvijas Universitātes 74. konferences Medicīnas sekcija. Rīga, Latvia: Latvijas Universitāte; 2016.
11. U. Kojalo, D. Šantare, I. Kojalo, L. Zalaiskalna, M. Leja. Characteristics of the groups of non-compliance of colorectal cancer screening pilot study in Latvia. Latvijas Universitātes 74. konferences Medicīnas sekcija. Riga, Latvia: Latvijas Universitāte; 2016.
12. R. Škapars, M. Leja, H. Amal, I. Lašina, A. Sīviņš, G. Ancāns, et al. Volatile organic compound day-to-day variability detecting gastric cancer. Latvijas Universitātes 74. konferences Medicīnas sekcija. Rīga, Latvia: Latvijas Universitāte; 2016.
13. P. Krike, I. Polaka, D. Santare, S. Isajevs, I. Liepniece-Karele, E. Savvidou, et al. Pepsinogens and gastrin-17 in corpus-restricted gastritis. Latvijas Universitātes 74. konferences Medicīnas sekcija. Rīga, Latvia: Latvijas Universitāte; 2016.
14. L. Lauka, I. Jelovskis, R. Škapars, S. Gerskis, R. Lunins, G. Ancans, et al. Influence of preoperative chemotherapy on intraoperative complications and morbidity after hepatectomies for colorectal cancer patients with liver metastases. Latvijas Universitātes 74. konferences Medicīnas sekcija. Riga, Latvia: Latvijas Universitāte; 2016.
15. L. Lauka, I. Jelovskis, R. Škapars, R. Lunins, A. Rudzats, V. Gibietis, et al. Risk factros for postoperative complications after hepatic resection in patients with colorectal liver metastases. Latvijas Universitātes 74. konferences Medicīnas sekcija. Riga, Latvia: Latvijas Universitāte; 2016.
16. K. Purmalis, E. Kasalis, D. Santare, I. Kojalo, M. Leja. Colorectal cancer screening cost efficiency analyses using variety of tests under different scenarious. Latvijas Universitātes 74. konferences Medicīnas sekcija. Rīga, Latvia: Latvijas Universitāte; 2016. pp. 110.
17. I. Lašina, E. Gašenko, R. Škapars, A. Sīviņš, V. Boka, U. Vikmanis, et al. Gaistošie biomarķieri kuņģa un kolorektālo neoplāziju noteikšanai un raksturošanai (VOLGACORE). Latvijas Universitātes 74. konferences Medicīnas sekcija. Rīga, Latvia: Latvijas Universitāte; 2016.
18. I. Lasina, E. Gasenko, R. Skapars, A. Sivins, V. Boka, U. Vikmanis, et al. Smart phone for disease detection from exhaled breath: brief project overview. Latvijas Universitātes 74. konferences Medicīnas sekcija. Riga, Latvia: Latvijas Universitāte; 2016.
19. I. Apine, J. Pokrotnieks, M. Leja, I. Pukite, A. Supe, G. Krūmiņa. Magnetic resonance enterography with diffusion weighted imaging (DWI) sequence helps to reveal early inflammatory changes in patients with suspect bowel disease? Latvijas Universitātes 74. konferences Medicīnas sekcija. Rīga, Latvia: Latvijas Universitāte; 2016.
20. D. Santare, I. Kojalo, I. Polaka, M. Leja. The impact of colorectal cancer alarm symptoms on participation in colorectal cancer screening and faecal occult blood test results. Latvijas Universitātes 74. konferences Medicīnas sekcija. Riga, Latvia: Latvijas Universitāte; 2016.
21. A. Dekante, I. Kikuste, U. Kojalo, K. Funka, V. Putnins, M. Sceruks, et al. Low prevalence of celiac disease in functional dyspepsia and irritable bowel syndrome. Latvijas Universitātes 74. konferences Medicīnas sekcija. Rīga, Latvia: Latvijas Universitāte; 2016.
22. Ilva Pole, Inta Jansone, Ģirts Šķenders, Anda Nodieva, Iveta Ozere, Viktorija Igumnova, Renāte Ranka. Mycobacterium tuberculosis Austrumāzijas līnijas genotipiskais raksturojums Latvijā. RSU Zinātniskā konference, posteris, tēzes, 17.-18.03.2016. Rīga, Latvija.